Navigation Links
Citicoline Supplement Doesn't Help Treat Brain Injury, Study Finds
Date:11/20/2012

TUESDAY, Nov. 20 (HealthDay News) -- The supplement citicoline does nothing to help improve brain function in patients with traumatic brain injury, a new study finds.

In the United States, citicoline is widely available at health food stores as a nutraceutical -- a product that reportedly provides health and medical benefits -- and is used by patients with a range of neurologic disorders.

Citicoline is also approved for treatment of traumatic brain injury, but such use had not been evaluated in a large, randomized clinical trial, noted Dr. Ross Zafonte, of Harvard Medical School, Spaulding Rehabilitation and Massachusetts General Hospital in Boston, and colleagues.

Their phase 3 clinical trial included more than 1,200 patients with mild, moderate or severe brain injuries. The patients started taking either citicoline or an inactive placebo within 24 hours of their injury and continued the therapy for 90 days.

Brain function tests conducted after the treatment period showed little difference between the two groups of patients. Rates of improvement ranged from about 35 percent to 86 percent in the citicoline group, similar to 36 percent to 84 percent observed in the placebo group.

A second evaluation, conducted six months after the brain injury, again revealed little difference between patients who took citicoline and those who took the placebo, according to the study published in the Nov. 21 issue of the Journal of the American Medical Association.

One expert said the study findings are disheartening.

The lack of any therapeutic effect "is another disappointment for individuals with traumatic brain injury," said Wayne Gordon, vice chair of the department of rehabilitation medicine at the Mount Sinai School of Medicine in New York City. He said "it highlights the fact that traumatic brain injury as an injury is not 'one-size-fits-all' and research is needed to develop approaches to the better classification of brain injury."

The study authors agreed, saying their findings suggest that the "worldwide use of citicoline for traumatic brain injury should now be questioned."

Dr. Danny Liang is a neurosurgeon at the Cushing Neuroscience Institute, part of the North Shore-LIJ Health System, in Manhasset, N.Y. He said that the new study "gives the medical community the most objective way to evaluate this potential therapy."

However, "this was a well-designed study that unfortunately gave disappointing results," Liang said.

More information

The U.S. National Institute of Neurological Disorders and Stroke has more about traumatic brain injury.

-- Robert Preidt

SOURCES: Wayne A. Gordon, Ph.D., Jack Nash Professor and vice chair, department of rehabilitation medicine, Mount Sinai School of Medicine, New York City; Danny Liang, M.D., neurosurgeon, Cushing Neuroscience Institute, North Shore-LIJ Health System, Manhasset, N.Y.; Nov. 21, 2012, Journal of the American Medical Association;Journal of the American Medical Association, news release, Nov. 20, 2012


'/>"/>
Copyright©2012 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Fish, But Not Fish Oil Supplements, May Shield Against Stroke
2. Supplement of Red Wine Ingredient Wont Help Healthy Women: Study
3. Vitamin D Supplements Wont Help Cholesterol Levels: Study
4. Calcium, Vitamin D Supplements May Pose Risks for Men With Prostate Cancer
5. Study questions value of calcium and vitamin D supplements
6. Nothing Natural About Dietary Supplement DMAA: Study
7. Stimulant marketed as natural in sports supplement actually of synthetic origin
8. Iron supplements can reduce fatigue in nonanemic women
9. Heuer M.D. Research Announces CardiaShred™ - First Medical Doctor Formulated, Heart Healthy Weight Loss, Energy and Lean Muscle Building Supplement
10. SupplementsToWeightLoss LLC (DBA: PharmaCo Labs) and also Classe Wines LLC announced that they have signed a 5 years lease on a warehouse
11. True-Dose to Exhibit Liquid Pet Supplements at the Cardinal Health Retail Business Conference in Orlando, FL on July 11-14
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Citicoline Supplement Doesn't Help Treat Brain Injury, Study Finds
(Date:3/23/2017)... ... March 23, 2017 , ... The Boulevard is honored ... 2pm. All events will be located in the Main West Entrance of The ... Child ID event. No appointment is necessary and each child with a parent or ...
(Date:3/23/2017)... (PRWEB) , ... March 23, 2017 , ... “Wounded Woman ... “Wounded Woman Be Ye Healed-Passing On A Legacy” is the creation of published author, ... founder of Comfortbearers grief ministry. She has been happily married to her husband, ...
(Date:3/23/2017)... ... ... “The Trainer”: an electrifying and suspenseful gunslinger novel with a twist. “The ... imagination and an enthusiasm for action and adventure stories. , Published by ... sat looking at the thirty-three notches that lined the edges of the wooden grip ...
(Date:3/22/2017)... ... March 22, 2017 , ... ... publication of the first issue of its companion print magazine. The new magazine, ... cosmetic surgery thanks to information provided by board-certified doctors from across the country. ...
(Date:3/22/2017)... ... March 22, 2017 , ... The ... inhibitor prior authorization (PA) form for prescribers to improve patients’ access to the ... helpful tools published as part of the article entitled “PCSK9 Inhibitor Access ...
Breaking Medicine News(10 mins):
(Date:3/22/2017)... , 22 de marzo de 2017   ... líder de soluciones de productos y servicios para ... que ha adquirido EPL Archives, Inc., una organización ... clientes en todo el ciclo de vida de ... una muestra de archivo, almacenamiento de documentos y ...
(Date:3/22/2017)... CAESAREA, Israel, March 22, 2017  DarioHealth Corp. ... with mobile health and big data solutions, today ... and twelve month period ended December 31, 2016. ... revenues of $2.8 million, increased 241% compared to ... quarterly revenue growth throughout the entire year  ...
(Date:3/22/2017)... , March 22, 2017 Ampio Pharmaceuticals, ... development of Ampion™, a low molecular weight fraction ... announced that it is re-issuing its previous release that ... certain disclosures that are required under the NYSE ... are these additional disclosures along with the previously ...
Breaking Medicine Technology: